Author:
Thompson Alexander J.V.,Nguyen Tin,Iser David,Ayres Anna,Jackson Kathy,Littlejohn Margaret,Slavin John,Bowden Scott,Gane Edward J.,Abbott William,Lau George K.K.,Lewin Sharon R.,Visvanathan Kumar,Desmond Paul V.,Locarnini Stephen A.
Reference36 articles.
1. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B;Fried;Hepatology,2008
2. A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels;Wiegand;Antivir Ther,2008
3. In patients with HBeAg-negative chronic hepatitis B HBsAg serum levels early during treatment with peginterferon alfa-2a predict HBsAg clearance 4 years post-treatment;Marcellin;Hepatology,2008
4. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B;Brunetto;Hepatology,2009
5. Prediction of treatment-related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels;Manesis;Antivir Ther,2007
Cited by
369 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献